BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 29364100)

  • 1. Unsuccessful transjugular intrahepatic portosystemic shunt for a patient with right heart failure and portal hypertension.
    Graus L; Verresen L; De Vusser P; Verbrugge FH; Caenepeel P
    Acta Gastroenterol Belg; 2017; 80(1):63-66. PubMed ID: 29364100
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of transjugular intrahepatic portosystemic shunt (TIPS) in the management of portal hypertension.
    Colombato L
    J Clin Gastroenterol; 2007; 41 Suppl 3():S344-51. PubMed ID: 17975487
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combined transjugular intrahepatic portosystemic shunt and other interventions for hepatocellular carcinoma with portal hypertension.
    Qiu B; Zhao MF; Yue ZD; Zhao HW; Wang L; Fan ZH; He FL; Dai S; Yao JN; Liu FQ
    World J Gastroenterol; 2015 Nov; 21(43):12439-47. PubMed ID: 26604651
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Parallel transjugular intrahepatic portosystemic shunt for controlling portal hypertension complications in cirrhotic patients.
    He FL; Wang L; Yue ZD; Zhao HW; Liu FQ
    World J Gastroenterol; 2014 Sep; 20(33):11835-9. PubMed ID: 25206289
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk Factors for Hepatic Encephalopathy after Transjugular Intrahepatic Portosystemic Shunt in Patients with Hepatocellular Carcinoma and Portal Hypertension.
    Yao J; Zuo L; An G; Yue Z; Zhao H; Wang L; Liu F
    J Gastrointestin Liver Dis; 2015 Sep; 24(3):301-7. PubMed ID: 26405702
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Transjugular intrahepatic portosystemic shunt (TIPS) for the treatment of complications of portal hypertension in patients with liver cirrhosis].
    Grønbaek H; Astrup LB; Nielsen DT; Vilstrup H
    Ugeskr Laeger; 2003 Jan; 165(5):439-42. PubMed ID: 12599838
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transjugular intrahepatic portosystemic shunt: A promising therapy for recompensation in cirrhotic patients.
    Jin YN; Zhang W
    World J Gastroenterol; 2024 Apr; 30(16):2285-2286. PubMed ID: 38690019
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CXCL9 is a prognostic marker in patients with liver cirrhosis receiving transjugular intrahepatic portosystemic shunt.
    Berres ML; Asmacher S; Lehmann J; Jansen C; Görtzen J; Klein S; Meyer C; Strunk HM; Fimmers R; Tacke F; Strassburg CP; Trautwein C; Sauerbruch T; Wasmuth HE; Trebicka J
    J Hepatol; 2015 Feb; 62(2):332-9. PubMed ID: 25457205
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transjugular intrahepatic portosystemic shunt prior to cardiac surgery with cardiopulmonary bypass in patients with cirrhosis and portal hypertension.
    Semiz-Oysu A; Moustafa T; Cho KJ
    Heart Lung Circ; 2007 Dec; 16(6):465-8. PubMed ID: 17446133
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transjugular intrahepatic portosystemic shunt: impact on systemic hemodynamics and renal and cardiac function in patients with cirrhosis.
    Busk TM; Bendtsen F; Poulsen JH; Clemmesen JO; Larsen FS; Goetze JP; Iversen JS; Jensen MT; Møgelvang R; Pedersen EB; Bech JN; Møller S
    Am J Physiol Gastrointest Liver Physiol; 2018 Feb; 314(2):G275-G286. PubMed ID: 29074483
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of transjugular intrahepatic portosystemic shunt treatment of patients with liver cirrhosis and portal hypertension: Case series.
    Zheng D; Yu J; Li H; Gan H; Wang J; Jiang T; Ren H; Wu F
    Medicine (Baltimore); 2021 Jul; 100(27):e26610. PubMed ID: 34232216
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transjugular intrahepatic portosystemic shunt for portal vein thrombosis with symptomatic portal hypertension in liver cirrhosis.
    Han G; Qi X; He C; Yin Z; Wang J; Xia J; Yang Z; Bai M; Meng X; Niu J; Wu K; Fan D
    J Hepatol; 2011 Jan; 54(1):78-88. PubMed ID: 20932597
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transjugular intrahepatic portosystemic shunt placement before abdominal intervention in cirrhotic patients with portal hypertension: lessons from a pilot study.
    Fares N; Robic MA; Péron JM; Muscari F; Otal P; Suc B; Vinel JP; Bureau C
    Eur J Gastroenterol Hepatol; 2018 Jan; 30(1):21-26. PubMed ID: 29049129
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transjugular intrahepatic portosystemic shunts and portal hypertension-related complications.
    Siramolpiwat S
    World J Gastroenterol; 2014 Dec; 20(45):16996-7010. PubMed ID: 25493012
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Portosystemic pressure gradient during transjugular intrahepatic portosystemic shunt with Viatorr stent graft: what is the critical low threshold to avoid medically uncontrolled low pressure gradient related complications?
    Chung HH; Razavi MK; Sze DY; Frisoli JK; Kee ST; Dake MD; Hellinger JC; Kang BC
    J Gastroenterol Hepatol; 2008 Jan; 23(1):95-101. PubMed ID: 18171347
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Transjugular intrahepatic portosystemic shunt (TIPS)].
    Peck-Radosavljevic M; Pidlich J
    Wien Klin Wochenschr; 2000 Nov; 112(22):947-54. PubMed ID: 11142132
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Urinary aquaporin-2 excretion before and after transjugular intrahepatic portosystemic shunt insertion for refractory ascites.
    Geilswijk M; Thomsen KL; Pedersen EB; Vilstrup H; Grønbæk H
    Scand J Gastroenterol; 2015 Apr; 50(4):454-61. PubMed ID: 25637473
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Does Transjugular Intrahepatic Portosystemic Shunt Stent Differentially Improve Survival in a Subset of Cirrhotic Patients?
    Trebicka J
    Semin Liver Dis; 2018 Feb; 38(1):87-96. PubMed ID: 29471569
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship between pre-TIPS hepatic hemodynamics and postoperative incidence of hepatic encephalopathy.
    Deng D; Liao MS; Qin JP; Li XA
    Hepatobiliary Pancreat Dis Int; 2006 May; 5(2):232-6. PubMed ID: 16698582
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Direct intrahepatic portocaval shunt (DIPS) or transjugular transcaval intrahepatic portosystemic shunt (TTIPS) to treat complications of portal hypertension: Indications, technique, and outcomes beyond Budd-Chiari syndrome.
    Artru F; Moschouri E; Denys A
    Clin Res Hepatol Gastroenterol; 2022 Apr; 46(4):101858. PubMed ID: 34999250
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.